|
AIS
Products on the Medicare Part D Prescription Drug Benefit |
MEDICARE PART D COMPLIANCE NEWS, news and strategies
on implementation and compliance with the new Medicare drug benefit
marketing, enrollment, formularies, rebates, claims pricing,
and fraud, waste and abuse. 12 issues annually ($467 per year) or
2-month intro ($71 for 2 issues); subscriptions include print copy
and e-mail delivery of the newsletter, biweekly "Part D E-Letters"
and access to a special Part D Web site for easy access to all original
documents.
MEDICARE PART D: A COMPREHENSIVE ANALYSIS OF CMS RULES distills from thousands of pages of CMS regulations and guidance the major rules, guidelines and deadlines you need to comprehend the complex Medicare drug benefit program. It includes nine detailed chapters on sponsors, eligibility and enrollment, formularies, CMS enforcement and much more. ($124)
PART D APPEALS & GRIEVANCES: STRATEGIES FOR MINIMIZING COMPLIANCE RISKS examines key issues surrounding Part D appeals and grievances. This report, based on a January 25, 2007, audioconference, shares expert advice on how to structure an effective appeals and grievances procedure — one that will help you avoid becoming a target of CMS enforcement. ($137) PDF version also available.
|
Upcoming
and Recent Audioconferences & Seminars on Medicare Part D |
FINAL MEDICARE MARKETING RULES: THE TIME TO CHANGE AND COMPLY IS NOW!, a 90-minute audioconference on October 23, 2008. Gorman Health Group’s managed care marketing and regulatory experts
Jeff Fox and
Jean LeMasurier will detail the steps you should be taking to ensure that your MA and Part D marketing is effective and compliant, both in the upcoming open-enrollment season and beyond. ($329)
VACCINE COVERAGE AND BILLING STRATEGIES UNDER PART D, a recording of a 90-minute audioconference held on September 25, 2008.
Andrea Serrate, CPA, vice president of specialty and payer services for Poc Network Technologies, Inc., provides valuable intelligence about CMS’s new vaccine coverage and administration billing requirements and options. Learn how to cover and bill for vaccines correctly to avoid CMS sanctions and enforcement action. ($329)
NEW MEDICARE ADVANTAGE AND PART D MARKETING RULES: KEY STRATEGIES FOR HEALTH PLANS, a recording of 90-minute audioconference held on June 5, 2008. Find out what steps you need to take as soon as possible, to ensure that your Medicare Advantage and Part D marketing is both effective and compliant under the CMS rules released May 8 — from
Gorman Health Group’s Jeff Fox and Mary Kaye Thibert. ($329)
PART D ENFORCEMENT PITFALLS: HOW TO IDENTIFY AND ELIMINATE FRAUD AND ABUSE IN YOUR DOWNSTREAM ENTITIES, a CD of a 90-minute audioconference
held on March 13, 2008. Find out urgent new compliance challenges Part D plans face in light of CMS’ recently finalized regs that increase sponsor responsibilities for downstream entities … and learn steps you can take to identify and eliminate fraud and abuse at the various contact points for beneficiaries. Hear from
Susan Hayes, principal and founder of Pharmacy Outcome Solutions and
Steve Arbaugh, principal with ATTAC Consulting Group, LLC. ($329)
STRATEGIES FOR IMPROVING THE ACCURACY OF PART D BIDS ... AND AVOIDING MULTI-MILLION-DOLLAR PDE RECONCILIATIONS, a 90-minute audioconference on December 13, 2007. Get the specifics of winning strategies for PDE data tracking and reconciliation, in time to prepare more accurate bids in the spring — from
Jana Furda, president of product development for Plan Data Management, Inc. ($329)
UPCOMING PART D AUDITS AND ENFORCEMENT: STRATEGIES FOR PREPARING YOUR PLAN AND PBM, a CD of a 90-minute audioconference held on September 20, 2007. Hear the details of urgent new compliance challenges Part D plans and PBMs face, and learn practical steps you can take to prepare for inevitable CMS audits and aggressive government enforcement — from ATTAC Consulting Group’s
Steve Arbaugh and
Susan Roberts. ($322)
PART D DRUG REBATES: STRATEGIES FOR MINIMIZING A SERIOUS RISK OF FRAUD AND ABUSE, a CD of a 90-minute audioconference
held on June 14, 2007. Learn how to identify and avoid fraud-and-abuse risks in drug-rebate negotiations, and stay in compliance with Part D requirements. Speakers are
Gina M. Smith, of counsel in the Litigation Department of Ballard Spahr Andrews & Ingersoll, LLP; and
Sam Rajan, R.Ph., vice president of clinical operations, and
Daniel Best, director of manufacturer-trade relationships, at MemberHealth, a pharmacy benefit manager and national Medicare Part D sponsor. ($322)
A full listing
of AIS products and audioconferences is available at the AIS
MarketPlace.